BioCardia, Inc. — Form 10-Q
Filed August 12, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Peter Altman (President/CEO) and David McClung (CFO) certified the June 30, 2026 10-Q under SOX 302 and 906. Both officers attest that the report contains no untrue material statements, that financial statements fairly present the company's condition, and that disclosure controls and internal financial reporting controls are designed and operating effectively. No material weaknesses, deficiencies, or fraud involving management were disclosed.
Why this rating
Boilerplate SOX certification with no substantive disclosure changes, material weaknesses, or control failures. Routine periodic filing requirement.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.